Useful Resources
A new study demonstrates the connection between subpotent generic fingolimod capsules and relapse events following a medication switch from Gilenya® capsules to generic fingolimod capsules. Read our article to find out more.
We analyzed the fingolimod content of FDA-approved generic fingolimod capsules from four different manufacturers and found a large variability in fingolimod content between manufacturers, with two generic fingolimod products below the required fingolimod dosage. Read our whitepaper to find out more.
Find out more about TASCENSO ODT in our brochure.
Find out more about the support available to patients taking TASCENSO ODT.
Find helpful information about MS.
A leading resource for the entire MS community, improving lives today through vital services and support.
Follow us
Join our TASCENSO ODT Instagram community for resources and news.
Join our TASCENSO ODT Facebook community for resources and news.
Join our Cycle Vita Facebook community to stay up to date with news and events.